Special Reports

Making sense of artificial intelligence

Artificial intelligence (AI), the ability of computer systems to simulate or imitate human intelligence, is quietly transforming our daily lives. But how does it work? And how does it benefit busy trademark professionals? We’ll answer these important questions in our latest white paper: Making sense of artificial intelligence.

The cost of free: Industrial design research

Industrial design infringement is on the rise. As the volume of industrial design registrations increases, it becomes ever more important to thoroughly vet industrial designs prior to filing. In an effort to save money, some IP professionals choose free methods of prior art searching. While these methods may seem cost effective, are they an efficient […]

Use as directed: Navigating the complexities of pharmaceutical trademarks

The global market for pharmaceutical products reached $1.2 trillion in 2018 – up $100 billion from the prior year. This is projected to reach $1.5 trillion by 2021. New developments in biotechnology, nanotechnology and digital medicine are rapidly transforming the definition of pharma products. These trends are creating an ever-more crowded and complex brand landscape. […]

2019 Trademark Ecosystem

The 2019 Trademark Ecosystem is a full in-depth report highlighting the major changes in the trademark space, including identifying key players and forces affecting trademark infringement. As more trademarks enter the market, the challenge and complexity of protecting and preventing infringement increases. Key findings Steep rise in trademark filing activity, Infringement is here to stay […]

Chinese brands go global

Overview Following in the footsteps of mainland China’s domestic trademark register, which is the largest in the world, Chinese brands are now appearing on foreign trademark registers in increasingly large numbers. Details CompuMark™ has been tracking the drive from mainland China to build global brands, and this report shows that – in just four years […]

What’s new at CompuMark for pharmaceutical companies

Developing a PTO-approved mark is a challenge for any organization. But for pharmaceutical companies, the journey doesn’t end there. US Food and Drug Administration (FDA) requirements mean a second set of considerations. At CompuMark™, we are committed to providing you with best-in-class products and services designed to navigate these challenges.

2018 Trademark Ecosystem

In a recent independent survey of trademark professionals, 74% said they experienced trademark infringement in the past year—and 1/3 of them had to change their brand names due to infringement.

Strategies for brand protection and clearance in the mobile age

Brands are going mobile in a big way. And no wonder. Consumers now spend more time with mobile apps than with desktop web access. Global mobile users will grow from 65% (4.8B) in 2015 to 70% (5.5B) of the world’s population by 2020.1 Given this new reality, brand owners cannot afford to overlook mobile apps […]

U.S. Trademark Filing Strategies for Foreign Applicants: How to avoid common mistakes

For brand owners outside the United States, the process of securing trademark rights in the U.S. presents some important differences. Understanding these differences is the key to avoiding costly mistakes by foreign applicants. In this informative article, international intellectual property attorney William E. O’Brien explains three common mistakes made when filing trademarks with the U.S. […]